Quantcast

Pharma news

Global Colorectal Cancer Therapeutics Market 2019-2023 | Evolving Opportunities with Bristol-Myers Squibb Company and Eli Lilly and Company | Technavio

LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global colorectal cancer therapeutics market since 2015, and the market is poised to grow

Posted in news | Leave a comment

Global Cholangiocarcinoma Therapeutics Market 2019-2023 | Evolving Opportunities with Bristol-Myers Squibb Company and Eli Lilly and Company | Technavio

LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global cholangiocarcinoma therapeutics market since 2018, and the market is poised to grow by

Posted in news | Leave a comment

OncoSec Announces the Appointment of Robert J. DelAversano, C.P.A, as Principal Accounting Officer and Controller

SAN DIEGO & PENNINGTON, N.J.–(BUSINESS WIRE)–OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer

Posted in news | Leave a comment

Charles River Laboratories Schedules Fourth-Quarter 2019 Earnings and 2020 Guidance Release and Conference Call

WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #earnings–Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2019 financial results and provide

Posted in news | Leave a comment

Vertex to Announce Full-Year and Fourth-Quarter 2019 Financial Results on January 30

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its full-year and fourth-quarter 2019 financial results on Thursday, January 30, 2020

Posted in news | Leave a comment

FDA Approves TEPEZZATM (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)

— First and only FDA-approved medicine for TED, a serious, progressive, vision-threatening rare disease — — Clinical improvements were seen

Posted in news | Leave a comment

Tiziana Life Sciences Announces Appointment of Mr. Gregor MacRae to strengthen the Board

NEW YORK & LONDON–(BUSINESS WIRE)–Tiziana Life Sciences plc (“Tiziana” or the “Company”) (Nasdaq: TLSA / AIM: TILS), a biotechnology company

Posted in news | Leave a comment

Global Clinical Trial Packaging Market Expected to Grow with a CAGR of Over 4% During the Forecast Period, 2020-2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Packaging Market by End-user and Geography – Forecast and Analysis 2020-2024” report has been added to

Posted in news | Leave a comment

Pemphigus Vulgaris, Pipeline Review, H2 2019 – Biogen Inc, Declion Pharmaceuticals Inc, Novartis AG & Pharmapraxis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pemphigus Vulgaris – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary This latest

Posted in news | Leave a comment

Post Menopausal Osteoporosis – Pipeline Review, H2 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Post Menopausal Osteoporosis – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary This

Posted in news | Leave a comment

Eisai, Biogen kick-off phase 3 testing early Alzheimer’s disease antibody, amid dropping aducanunab trial. Eisai’s US company presents AD pipeline

Eisai Co said Friday thata global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid beta protofibril antibody, in patients with early Alzheimer’s disease has been initiated.

Posted in Approval, Asia, Europe, North America, Regions | Tagged , , | Leave a comment

ProMIS offeri potential significant advantage over aducanumab, learns from mistakes

ProMIS Neurosciencesissued a pres release Friday, raising urgency to selectively target the toxic oligomer with exacting precision as part of the global effort to develop disease-modifying therapies for Alzheimer’s disease (AD), upon Biogen’s and Eisai’s dropping two alte-stage clinical trials of aducanumab.

Posted in Approval, North America | Tagged , , , , | Leave a comment

Alvogen’s Taiwan company – Lotus – exchange stake with Fuji Pharma

@alvogenpr subsidiary in Taiwan, Lotus Pharmaceuticals today announced capital and business collaboration agreements with Fuji Pharma in Japan, as Fuji has acquired a 2.0% stake in Lotus for approximately US$20 million (or NT$ 617 million, JPY 2.2 billion). Lotus has also acquired 3.9% stake in Fuji for an equal sum.

Posted in Approval, Asia, Europe, news | Tagged , , | Leave a comment

Gelesis Announces Three Presentations at Annual Endocrine Society Meeting

BOSTON–(BUSINESS WIRE)–Gelesis, a biotechnology company developing first-in-class mechanotherapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI)

Posted in Approval, news, North America | Tagged | Leave a comment

CB Therapeutics Secures new Research and Production Facility

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is an innovative biotechnology company focusing on research and production of cannabinoids. The company utilizes its

Posted in Approval, news | Tagged | Leave a comment

Vaxart Announces Closing of Registered Direct Offering of Common Stock

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather

Posted in Approval, news, North America | Tagged | Leave a comment

First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research Institute

STERLING, Kan.–(BUSINESS WIRE)–Genzada Pharmaceuticals USA Inc. (Genzada), a subsidiary of Ionics Life Sciences Limited, announced today that the first patient

Posted in Approval, news, North America, Regions | Tagged , , , , | Leave a comment

Transgene: A Positive 2018, Moving Ahead with a Strong Portfolio

2018 Full-year results and business update Clinical trials set to announce key data in 2019 Invir.IO™ platform designed to deliver

Posted in Approval, news | Tagged | Leave a comment

Center for Gene and Cell Therapy Co-founded by Miltenyi and ATLATL in Shanghai

SHANGHAI–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Shanghai?src=hash" target="_blank"gt;#Shanghailt;/agt;–To accelerate the development of cell and gene therapy, ATLATL Center and Miltenyi Biotec have cooperated to build ATLATL-MACS Center

Posted in Approval, Asia, news, Regions | Tagged | Leave a comment

MichBio Announces 7th Annual “Michigan Biosciences Day at the Capitol,” Seeks Participants

ANN ARBOR, Mich. & LANSING, Mich.–(BUSINESS WIRE)–Michigan’s premier biosciences industry trade organization, MichBio, presents its annual Michigan Biosciences Day at

Posted in Approval, news | Tagged | Leave a comment